Institute 1
Advanced Psychopharmacology Institute
Tuesday, October 24
8:00 a.m. – 5:00 p.m. (ticket)
Laurence L. Greenhill, M.D., Chair
Over the past decade, there has been a rapid increase in knowledge regarding the pharmacotherapy treatment of children and adolescents with various psychiatric disorders. However, uncertainty continues regarding the safety of several medications used for pediatric psychiatric disorders. Moreover, due to the recent controversies over suicidality with the use of antidepressants, cardiac problems with stimulants, and metabolic syndrome with antipsychotics, clinicians are confronted with contradictory information. Parents and the media are increasingly concerned about the use of pharmacotherapy even
with children for whom these treatments have been shown to be useful and safe. This Institute provides up-to-date information about the practical use and safety of medications for the treatment of pediatric psychopathology. Presenters provide evidence-based data (both negative and positive) and/or systematic clinical observations of treatment of various major psychiatric disorders. When indicated, case presentations are included.
Psychopharmacological Treatments for ADHD in the Face of Regulatory Concerns/Case Presentations
Laurence L. Greenhill, M.D.
Psychopharmacological Treatments for Depression in Children and Teens Considering Regulatory Concerns/Case Presentations
Graham J. Emslie, M.D.
Pharmacological Management of Anxiety Disorders in Children: Recent Research, Acute Versus Maintenance Treatment, and Treatment in the Presence of Comorbid Disorder/Case Presentations
John T. Walkup, M.D.
Evidence-Based Treatment of Children and Adolescents with Bipolar Disorder/Case Presentations
Melissa P. DelBello, M.D.
Pharmacological Management of Children and Adolescents with OCD and Tourette’s Syndrome
Barbara J. Coffey, M.D., M.S.
Psychopharmacology of ADHD in an Era of Regulatory Concern
Christopher J. Kratochvil, M.D.
Endocrine Effects of Drugs
Harold E. Carlson, M.D.
Autism and Pervasive Developmental Disorders
Lawrence Scahill, M.S.N., Ph.D.
Advanced Psychopharmacology Institute
Tuesday, October 24
8:00 a.m. – 5:00 p.m. (ticket)
Laurence L. Greenhill, M.D., Chair
Over the past decade, there has been a rapid increase in knowledge regarding the pharmacotherapy treatment of children and adolescents with various psychiatric disorders. However, uncertainty continues regarding the safety of several medications used for pediatric psychiatric disorders. Moreover, due to the recent controversies over suicidality with the use of antidepressants, cardiac problems with stimulants, and metabolic syndrome with antipsychotics, clinicians are confronted with contradictory information. Parents and the media are increasingly concerned about the use of pharmacotherapy even
with children for whom these treatments have been shown to be useful and safe. This Institute provides up-to-date information about the practical use and safety of medications for the treatment of pediatric psychopathology. Presenters provide evidence-based data (both negative and positive) and/or systematic clinical observations of treatment of various major psychiatric disorders. When indicated, case presentations are included.
Psychopharmacological Treatments for ADHD in the Face of Regulatory Concerns/Case Presentations
Laurence L. Greenhill, M.D.
Psychopharmacological Treatments for Depression in Children and Teens Considering Regulatory Concerns/Case Presentations
Graham J. Emslie, M.D.
Pharmacological Management of Anxiety Disorders in Children: Recent Research, Acute Versus Maintenance Treatment, and Treatment in the Presence of Comorbid Disorder/Case Presentations
John T. Walkup, M.D.
Evidence-Based Treatment of Children and Adolescents with Bipolar Disorder/Case Presentations
Melissa P. DelBello, M.D.
Pharmacological Management of Children and Adolescents with OCD and Tourette’s Syndrome
Barbara J. Coffey, M.D., M.S.
Psychopharmacology of ADHD in an Era of Regulatory Concern
Christopher J. Kratochvil, M.D.
Endocrine Effects of Drugs
Harold E. Carlson, M.D.
Autism and Pervasive Developmental Disorders
Lawrence Scahill, M.S.N., Ph.D.
